P.S. Free 2026 Nursing ACNS dumps are available on Google Drive shared by FreePdfDump: https://drive.google.com/open?id=1lqiuKkC19fT8MFl-RXIs-HMrZbS5_Y12
We are concerted company offering tailored services which include not only the newest and various versions of ACNS practice materials, but offer one-year free updates services with patient staff offering help 24/7. So there is considerate and concerted cooperation for your purchasing experience accompanied with patient staff with amity. Their enrichment is dependable and reliable. You can find ACNS practice materials on our official website we will deal with everything once your place your order.
| Section | Weight | Objectives |
|---|---|---|
| APRN Core Competencies | 16% | - Advanced Pathophysiology - Advanced Health Assessment - Advanced Pharmacology |
| Clinical Practice | 46% | - Evaluation of Outcomes - Health Assessment and Diagnosis - Care Planning and Implementation - Health Promotion and Disease Prevention - Pharmacologic and Nonpharmacologic Management |
| Role and Professional Responsibility | 33% | - Quality Improvement and Safety - Education and Mentorship - Evidence-Based Practice and Research - Clinical Leadership and Consultation - Ethics and Legal Aspects |
| Health Care Systems and Policy | 5% | - Resource Management - Regulatory and Policy Frameworks - Healthcare Delivery Models |
All we want you to know is that people are at the heart of our manufacturing philosophy, for that reason, we place our priority on intuitive functionality that makes our ACNS Exam Question to be more advanced. So with our ACNS guide torrents, you are able to pass the exam more easily in the most efficient and productive way and learn how to study with dedication and enthusiasm, which can be a valuable asset in your whole life. It must be your best tool to pass your exam and achieve your target.
NEW QUESTION # 59
A 52-year old female is in the office with a new-onset of reflux esophagitis. You are assessing her and asking pertinent questions. What do you expect to find with her that would support this diagnosis?
Answer: A
Explanation:
When assessing a 52-year-old female patient presenting with new-onset reflux esophagitis, certain findings in her medical history and symptoms can support the diagnosis. Here are the pertinent factors to consider:
**Recent Initiation of Estrogen-Progestin Hormonal Therapy**: This is a significant factor to explore. Medications can impact the function of the gastrointestinal system, particularly the lower esophageal sphincter (LES). The LES is a critical barrier preventing the backflow of stomach contents, including acid, into the esophagus. Estrogen and progestin, components of many hormonal therapies, are known to potentially decrease LES pressure. This reduction in pressure can lead to or exacerbate gastroesophageal reflux disease (GERD), presenting as reflux esophagitis. Asking about the timing of hormonal therapy initiation and correlating it with the onset of reflux symptoms can provide valuable diagnostic insight.
**Symptoms Consistent with Reflux Esophagitis**: The patient may report classic symptoms such as heartburn, regurgitation of food or sour liquid, and chest pain. Additionally, symptoms like difficulty swallowing (dysphagia), a sensation of a lump in the throat, and chronic cough might also be present. These symptoms often worsen after eating, when lying down, or bending over.
**Lifestyle and Dietary Factors**: Inquiring about recent changes in diet, alcohol consumption, smoking habits, and body weight can be helpful. Increased intake of fatty foods, alcohol, caffeine, and smoking are known risk factors for GERD. Obesity also contributes to increased abdominal pressure, which can promote the reflux of acid into the esophagus.
**Active H. pylori Infection**: While Helicobacter pylori infection is primarily associated with gastritis and peptic ulcer disease, it can indirectly influence the development of reflux esophagitis. The infection can lead to changes in the stomach lining and potentially affect acid production and gastric emptying, which might exacerbate reflux symptoms.
**Exclusion of Other Causes**: It is also crucial to rule out other potential causes of the patient's symptoms. For instance, a report of melena (black, tarry stools) might suggest gastrointestinal bleeding, which requires immediate attention and a different diagnostic pathway. Similarly, symptoms like recent weight loss and fatigue might necessitate a broader investigation to rule out other systemic conditions. By exploring these aspects during the patient interview and examination, a more comprehensive understanding of the potential cause of the reflux esophagitis can be achieved, guiding appropriate management and treatment strategies.
NEW QUESTION # 60
When discussing Human Immunodeficiency virus (HIV) testing with a patient, the CNS knows:
Answer: C
Explanation:
The correct answer is: "The screening ELISA test (enzyme-linked immunosorbent assay) detects antibodies and is 99% sensitive and specific." It is important to clarify why this statement is correct and to address the misconceptions around HIV risk and testing. Firstly, the ELISA test is a widely used initial screening tool for detecting antibodies to HIV. Antibodies are proteins that the body produces in response to an infection. In the case of HIV, these antibodies generally develop within a few weeks to months after infection. The sensitivity and specificity of the ELISA test being around 99% means that the test is highly effective at correctly identifying those who have and do not have HIV. A test with 99% sensitivity will correctly identify 99% of people with the disease and miss 1%, while a test with 99% specificity will correctly rule out the disease in 99% of people who do not have the disease, mistakenly identifying 1% as positive.
Addressing the first statement, it is a misconception that only sexually active homosexual men are at risk for HIV. HIV can affect anyone, regardless of sexual orientation, age, race, or any other factor. It is transmitted through contact with infected bodily fluids such as blood, semen, vaginal fluids, and breast milk. This can happen through unprotected sexual activities with an infected person, sharing needles for drug use, receiving unsafe injections, transfusions, and from mother to child during childbirth or breastfeeding.
Furthermore, the statement about rechecking the ELISA test highlights the concept of the "window period." The window period is the time immediately after infection during which antibodies to HIV are not yet produced in high enough quantities to be detectable by the test. Therefore, if exposure to HIV is suspected, a follow-up test is recommended after the window period, typically around six months, to confirm the initial result. This protocol helps in capturing cases that might have been missed if tested too early after exposure.
Lastly, it is crucial to recognize broader risk factors beyond sexual orientation. Individuals with multiple sexual partners, those who engage in IV drug use, people with a history of sexually transmitted diseases (STDs), and those who were recipients of blood products between 1975 and 1985 (before widespread screening of the blood supply for HIV began) are also at increased risk. Understanding these factors can help in better targeting education, prevention, and testing efforts to those most at risk.
In summary, the CNS (Clinical Nurse Specialist) must be equipped with accurate and comprehensive knowledge about HIV transmission, testing, and the populations at risk. This ensures appropriate guidance and management of patients concerning HIV testing and prevention strategies.
NEW QUESTION # 61
The CNS understands that all of the following statements involving Pap smears are correct except:
Answer: D
Explanation:
The statement "The pap smear is a diagnostic test" is incorrect because a Pap smear is primarily a screening tool, not a diagnostic one. The purpose of a Pap smear, also known as a Pap test, is to screen for precancerous or cancerous cells on the cervix, which is the lower part of the uterus opening into the vagina. This test is intended to detect potentially precancerous and cancerous processes in the cervical epithelium, but it does not diagnose the condition definitively.
In contrast, a diagnostic test is used when there is a suspicion of disease, to establish a definitive diagnosis. For cervical health, this diagnostic test is typically a cervical biopsy. In a biopsy, a small sample of cervical tissue is removed and examined microscopically to determine whether cancerous or precancerous cells are present. This step is usually taken after an abnormal Pap smear result and provides a direct and more accurate assessment of the cervical tissue.
Additionally, a key aspect of understanding the limitations of a Pap smear includes recognizing its rate of false negatives, which ranges from 15% to 40%. A false negative result means that the test indicates there is no problem when, in fact, there might be an abnormality that was not detected. This underscores the importance of regular screening as recommended by healthcare guidelines, to increase the chances of detecting abnormalities over time.
Moreover, the adequacy of a Pap smear sample is crucial for accurate screening. A sample is considered satisfactory if it includes both squamous epithelial cells and endocervical cells. These cells are necessary for evaluating the transformation zone (the area where cervical precancers and cancers are most likely to develop) effectively. If endocervical cells are missing, it suggests that the transformation zone may not have been adequately sampled, and the test might need to be repeated to ensure a comprehensive assessment.
In summary, while the Pap smear is an essential tool in the cervical cancer screening process, it is not a diagnostic test. Its primary role is to identify individuals at higher risk who may need further diagnostic evaluation through procedures like a cervical biopsy. Understanding this distinction helps in effectively utilizing the Pap smear as part of a broader strategy for managing cervical health.
NEW QUESTION # 62
Of the following, which is an example of an impaired absorption reason contributing to iron deficiency?
Answer: D
Explanation:
Of the various conditions listed, gastrectomy is uniquely associated with impaired absorption of iron, contributing to iron deficiency. Gastrectomy, the surgical removal of all or part of the stomach, can significantly affect the body's ability to absorb nutrients, including iron. This is because the stomach plays a crucial role in the initial stages of iron absorption. During digestion, stomach acids help convert dietary iron into a form that is more easily absorbed in the intestines. With reduced stomach capacity or altered stomach function following gastrectomy, there is a decreased secretion of gastric acid, which is essential for iron absorption.
In contrast, the other conditions mentioned-Goodpasture syndrome, multiple gestation, and epistaxis-do not primarily involve impaired nutrient absorption. Goodpasture syndrome is an autoimmune disorder affecting the lungs and kidneys, leading to bleeding in the lungs and kidney dysfunction, but it does not directly impair gastrointestinal nutrient absorption. Multiple gestation increases the demand for iron due to the needs of more than one fetus, potentially leading to deficiency if the increased demand is not met through diet or supplements. However, it does not inherently affect the absorption processes in the digestive tract. Epistaxis, commonly known as nosebleeding, can cause iron deficiency through chronic blood loss, but again, it does not impact the absorption of iron in the gastrointestinal system.
Therefore, among the options provided, gastrectomy is the correct answer as it directly relates to an impaired absorption mechanism contributing to iron deficiency. This understanding highlights the importance of monitoring and potentially supplementing iron in patients who have undergone this surgical procedure to prevent or address iron deficiency anemia.
NEW QUESTION # 63
When managing the patient on Lithium therapy, which of the following would be least important for the ACNS to evaluate?
Answer: C
Explanation:
When managing a patient on lithium therapy, it is crucial to monitor several physiological parameters due to lithium's potential impacts on various organ systems. The question at hand involves identifying which tests are least important for the Advanced Practice Nurse (APN) to evaluate in the context of lithium therapy. Lithium primarily affects renal (kidney), cardiac (heart), and thyroid functions. Therefore, monitoring the status of these systems is critical. Let's analyze why this is so and why liver function tests, specifically alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH), are considered least important in this context:
**Renal Function:** Lithium is excreted primarily through the kidneys, and its use can lead to changes in renal function, including nephrogenic diabetes insipidus. Monitoring renal function is crucial, typically through tests such as blood urea nitrogen (BUN) and creatinine levels, to prevent and manage potential kidney damage or dysfunction.
**Cardiac Function:** Although less common, lithium can affect cardiac function. Electrocardiograms (ECGs) might be necessary for patients with pre-existing heart conditions or those who develop cardiac symptoms during treatment.
**Thyroid Function:** Lithium has a well-documented influence on thyroid function, often causing hypothyroidism. It is important to monitor thyroid function regularly, using tests for thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4).
**Electrolytes:** Lithium can influence electrolyte balances, particularly sodium levels, due to its effects on kidney function. Monitoring electrolytes is crucial, as disturbances can affect lithium levels and toxicity.
**Liver Function Tests (LFTs):** LFTs, including ALT, AST, and LDH, are often used to assess liver damage or disease. However, lithium is not primarily metabolized by the liver, and its direct impact on liver function is minimal compared to its effects on renal, cardiac, and thyroid functions. Therefore, while these tests are generally important in assessing overall health, they are less critical specifically for the management of lithium therapy unless there is a pre-existing liver condition or another specific clinical indication for their use. In conclusion, the monitoring of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) is considered least important specifically for lithium therapy. This is because lithium's primary adverse effects do not typically involve liver function. Instead, more attention should be given to renal, cardiac, and thyroid functions, along with electrolyte monitoring, to effectively manage and mitigate potential side effects associated with lithium treatment.
NEW QUESTION # 64
......
The best news is that during the whole year after purchasing our ACNS study materials , you will get the latest version of our ACNS exam prep for free, since as soon as we have compiled a new versions of the ACNS learning quiz, our company will send the latest one of our ACNS training engine to your email immediately. It will be quite fast and convenient to process and our systemw will auto inform you to free download as long as we update our exam dumps.
Latest ACNS Test Guide: https://www.freepdfdump.top/ACNS-valid-torrent.html
BONUS!!! Download part of FreePdfDump ACNS dumps for free: https://drive.google.com/open?id=1lqiuKkC19fT8MFl-RXIs-HMrZbS5_Y12